ArticleSleep & breathing = Schlaf & Atmung2026
Spectral analysis of ECG and SpO₂ for machine learning classification of Sleep-Disordered breathing.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSleep-disordered breathing (SDB), particularly obstructive sleep apnea (OSA), is prevalent in hospitalized patients, yet remains underdiagnosed due to limited screening tools. This pilot study aimed to develop and validate a machine-learning classifier using electrocardiogram (ECG) and pulse oximetry (SpO₂) waveforms to detect SDB, leveraging routinely collected physiological data to enable non-invasive, scalable screening in hospitalized patients.
methodsWe utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA) Sleep cohort, which included full overnight polysomnography (PSG). A total of 122 participants were randomly selected, enriched for severe OSA cases. Spectral analysis of R-R intervals and SpO₂ variability was performed, and a support vector machine (SVM) classifier was trained using a subset of subjects (n = 30). Performance was evaluated in a validation set (n = 92) using standard classification metrics with 95% CIs calculated.
resultsThe first-stage classifier (SVM-1) demonstrated high sensitivity (98.7%) and specificity (99.0%) in identifying respiratory events at the window level. The second-stage classifier (SVM-2) correctly classified OSA presence with 100% accuracy in the training set. When applied to the validation set, the combined model achieved a sensitivity of 72.3%, specificity of 73.3%, and F1-score of 73.1%. Performance was impacted by arrhythmias, and lack of direct respiratory effort measures.
conclusionA machine-learning model using routinely collected ECG and SpO₂ data shows promise for SDB detection but may require additional cardiopulmonary parameters for clinical decision-making in the ICU. Further validation with data collected in real-world ICU settings is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.